GB Patent

GB8630702D0 — Quinoline compound

Assigned to Wellcome Foundation Ltd · Expires 1987-02-04 · 39y expired

What this patent protects

The present invention is concerned with the compound of formula (I) <CHEM> and salts thereof.

USPTO Abstract

The present invention is concerned with the compound of formula (I) <CHEM> and salts thereof.

Drugs covered by this patent

Trulance (PLECANATIDE) · Salix

Patent Metadata

Patent number: GB8630702D0
Jurisdiction: GB
Classification: —
Expires: 1987-02-04
Drug substance claim: No
Drug product claim: No
Assignee: Wellcome Foundation Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.